Table 1.
Cohort variables | ||
Age | Median 75 (IQR 60–82) | |
Sex | ||
Male | 59 (53.2%) | |
Female | 52 (46.8%) | |
Smoking status | ||
Never | 34 (30.6%) | |
Current | 26 (23.4%) | |
Ex smoker | 16 (14.4%) | |
Data missing | 36 (31.5%) | |
Ethnicity | ||
Caucasian | 107 (96.4%) | |
Indian | 2 (1.8%) | |
Arab | 1 (0.9%) | |
Data missing | 1 (0.9%) | |
Charlson Comorbidity Index Score | Median 5 (IQR 4–6) | |
Indications for endoscopy | ||
Dyspepsia | 10 (9.0%) | |
Upper GI bleed | 61 (55.0%) | |
Fe deficiency anaemia | 21 (18.9%) | |
Weight loss | 7 (6.3%) | |
Abdominal pain | 1 (0.9%) | |
Vomiting/nausea | 6 (5.4%) | |
Other | 2 (1.8%) | |
No. of ulcers per index oesophago-gastroduodenoscopy (OGD) | Median 1.0 (Range 1–7) | |
Size of gastric ulcer (cm) | Median 4.0 (IQR 3–5) | |
Endoscopic appearance | ||
Superficial | 16 (14.4%) | |
Linear | 2 (1.8%) | |
Cratered | 92 (82.9%) | |
Superficial/linear | 1 (0.9%) | |
Ulcer location | ||
Cardia/Fundus | 6 (5.2%) | |
Body | 59 (50.9%) | |
Incisura | 8 (6.9%) | |
Antrum/pre-pyloric | 43 (37.1%) | |
Endoscopist's suspicion | ||
Non-suspicious | 38 (34.2%) | |
Suspicious | 65 (58.6%) | |
Data missing | 8 (7.2%) | |
H. pylori status | ||
Negative | 55 (49.5%) | |
Positive | 26 (23.4%) | |
Not tested | 30 (27.0%) | |
Histological diagnosis | ||
Benign | 69 (62.2%) | |
Adenocarcinoma | 34 (30.6%) | |
Lymphoma | 6 (5.4%) | |
Other neoplasia | 2 (1.8%) | |
- Pancreatic head adenocarcinoma - Neuroendocrine tumour |